The goal of all vitreous surgery is to perform the desired intraoperative intervention with minimum collateral damage in the most efficient way possible. An understanding of the principles of fluidics is of importance to all vitreoretinal surgeons to achieve these aims. Advances in technology mean that surgeons are being given increasing choice in the settings they are able to select for surgery. Manufacturers are marketing systems with aspiration driven by peristaltic, Venturi and hybrid pumps. Increasingly fast cut rates are offered with optimised, and in some cases surgeon-controlled, duty cycles. Function-specific cutters are becoming available and narrow-gauge instrumentation is evolving to meet surgeon demands with higher achievable flow rates. In parallel with the developments in outflow technology, infusion systems are advancing with lowering flow resistance and intraocular pressure control to improve fluidic stability during surgery. This review discusses the important aspects of fluidic technology so that surgeons can select the optimum machine parameters to carry out safe and effective surgery.

1.
Charles S, Calzada J, Wood B: Vitreous Microsurgery, ed 5. Philadelphia, Lippincott, Williams & Wilkins, 2010.
2.
Magalhães O Jr, Maia M, Maia A, Penha F, Dib E, Farah ME, Schor P: Fluid dynamics in three 25-gauge vitrectomy systems: principles for use in vitreoretinal surgery. Acta Ophthalmol 2008;86:156–159.
3.
Teixeira A, Chong LP, Matsuoka N, Arana L, Kerns R, Bhadri P, Humayun M: Vitreoretinal traction created by conventional cutters during vitrectomy. Ophthalmology 2010;117:1387–1392.
4.
Hubschman JP, Gupta A, Bourla DH, Culjat M, Yu F, Schwartz SD: 20-, 23-, and 25-gauge vitreous cutters: performance and characteristics evaluation. Retina 2008;28:249–257.
5.
Magalhães O Jr, Chong L, DeBoer C, Bhadri P, Kerns R, Barnes A, Fang S, Humayun M: Vitreous dynamics: vitreous flow analysis in 20-, 23-, and 25-gauge cutters. Retina 2008;28:236–241.
6.
DeBoer C, Fang S, Lima LH, McCormick M, Bhadri P, Kerns R, Humayun M: Port geometry and its influence on vitrectomy. Retina 2008;28:1061–1067.
7.
Abulon D, Buboltz D, Charles S: Fluidics behavior during vitrectomy. Retina Today, December 2010. http://bmctoday.net/retinatoday/2010/12/article.asp?f=fluidics-behavior-during-vitrectomy (accessed February 11, 2011).
8.
Hubschman JP, Bourges JL, Tsui I, Reddy S, Yu F, Schwartz SD: Effect of cutting phases on flow rate in 20-, 23-, and 25-gauge vitreous cutters. Retina 2009;29:1289–1293.
9.
Sato T, Kusaka S, Oshima Y, Fujikado T: Analyses of cutting and aspirating properties of vitreous cutters with high-speed camera. Retina 2008;28:749–754.
10.
Fang SY, DeBoer CM, Humayun MS: Performance analysis of new-generation vitreous cutters. Graefes Arch Clin Exp Ophthalmol 2008;246:61–67.
11.
Juan T, Hubschman JP, Eldredge JD: A computational study of the flow through a vitreous cutter. J Biomech Eng 2010;132:121005.
12.
Fluidics in modern vitrectomy. Retina Today Insert, April 2010. http://bmctoday.net/retinatoday/2010/04/insert/article.asp?f=fluidics-in-modern-vitrectomy (accessed February 8, 2011).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.